New Brunswick Scientific Co., Inc., Expands World's Most Extensive Shaker Line With Launch of Two New Incubator Models

EDISON, N.J., Sept. 12  /PRNewswire-FirstCall/ -- New Brunswick Scientific Co., Inc. (NBS) (NASDAQ:NBSC), today announced that it has rolled-out two new high-specification incubator shakers, the benchtop Innova(R) 40 and larger capacity Innova 43, bringing the total number of shakers in its already comprehensive product portfolio to more than 30 shaker models-the largest selection offered by any manufacturer.

Both new additions to the Innova(R) shaker family feature high-temperature capability to 80 degrees C, optional refrigeration and a programmable controller to automate changes to any operating parameter. These novel enhancements increase precision and efficiency for NBS' customers.

President and Chief Operating Officer James Orcutt said: "Accelerated, targeted new-product development is among several strategic initiatives upon which NBS is focused, and the results of this sustained effort are becoming increasingly evident as we move through the year. The roll-out of the Innova 40 and 43 models represents the first in a number of new-product launches scheduled for the second half of 2005.

"These latest shaker models not only extend and complement existing products but also offer the competitive advantage of state-of-the-art, multi- step programming capabilities as well as improvements to previous product features and optimized user-friendliness. We continue to invest in our aggressive product development program and expect a number of new roll-outs in the months ahead, all of which are intended to enhance shareholder value."

To be added to New Brunswick Scientific's e-mail distribution list, please click on the link below:

  http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html

  About New Brunswick Scientific


New Brunswick Scientific Co., Inc., is a leading global provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry. The Company's products are used in the creation, maintenance and control of physical and biochemical environments required for the growth, detection and storage of microorganisms for medical, biological and chemical applications, as well as environmental research and commercial product development. NBS is a forerunner in the research and development of pioneering equipment to meet the challenges of new areas of advancement in life science. Established in 1946, New Brunswick Scientific is headquartered in Edison, New Jersey, with sales and distribution facilities strategically located in the United States, Europe and Asia. For more information, please visit http://www.nbsc.com/ .

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward- looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of the Company. The forward-looking statements involve a number of risks and uncertainties, including but not limited to, changes in economic conditions, demand for the Company's products, pricing pressures, intense competition in the industries in which the Company operates, the need for the Company to keep pace with technological developments and respond in a timely manner to changes in customer needs, the Company's dependence on third-party suppliers, the effect on foreign sales of currency fluctuations, acceptance of new products, the labor relations of the Company and its customers and other factors identified in the Company's Securities and Exchange Commission filings. Forward-looking statements are based on management's current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from these expectations and assumptions due to changes in global political, economic, business, competitive, market, regulatory and other factors. The Company undertakes no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise. 

DATASOURCE: New Brunswick Scientific Co., Inc.



CONTACT:  Investors - Samuel Eichenbaum, Vice President, Finance and

Treasurer, New Brunswick Scientific Co., Inc., [phone], ;

Matthew J. Dennis, CFA, of NBS Investor Relations, Clear Perspective Group,

LLC, +1-440.353.0552, 



Web site:  http://www.nbsc.com/ 

Copyright